Ultrastructural and transcriptional profiling of neuropathological misregulation of CREB function

Cell Death and Differentiation

Volumn 17, Issue 10, 2010, Pages 1636-1644

  Valor, L M ^a   Jancic, D ^a   Lujan, R ^b   Barco, A ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

^b University of Castilla La Mancha   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME INHIBITION; EXCITOTOXICITY; GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION PROFILING; HERPES SIMPLEX VIRUS PROTEIN VMW65; HIPPOCAMPUS; INFLAMMATION; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; NEURONS; RECOMBINANT FUSION PROTEINS;

MUS;

EID: 77956697093     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.40     Document Type: Article

References (40)

1. Johannessen M, Delghandi MP, Moens U. What turns CREB on? Cell Signal 2004; 16: 1211-1227.
2. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999; 286: 2358-2361.
3. Papadia S, Stevenson P, Hardingham NR, Bading H, Hardingham GE. Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J Neurosci 2005; 25: 4279-4287.
4. Andreatta CP, Nahreini P, Hanson AJ, Prasad KN. Regulated expression of VP16CREB in neuroblastoma cells: analysis of differentiation and apoptosis. J Neurosci Res 2004; 78: 570-579.
5. Glover CP, Heywood DJ, Bienemann AS, Deuschle U, Kew JN, Uney JB. Adenoviral expression of CREB protects neurons from apoptotic and excitotoxic stress. Neuroreport 2004; 15: 1171-1175.
6. Lee B, Butcher GQ, Hoyt KR, Impey S, Obrietan K. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J Neurosci 2005; 25: 1137-1148.
7. Lonze BE, Riccio A, Cohen S, Ginty DD. Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 2002; 34: 371-385.
8. Parlato R, Rieker C, Turiault M, Tronche F, Schutz G. Survival of DA neurons is independent of CREM upregulation in absence of CREB. Genesis 2006; 44: 454-464.
9. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A et al. Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 2002; 31: 47-54.
10. Jancic D, Lopez de Armentia M, Valor LM, Olivares R, Barco A. Inhibition of cAMP response element-binding protein reduces neuronal excitability and plasticity, and triggers neurodegeneration. Cereb Cortex 2009; 19: 2535-2547.
11. Lopez de Armentia M, Jancic D, Olivares R, Alarcon JM, Kandel ER, Barco A. cAMP response element-binding protein-mediated gene expression increases the intrinsic excitability of CA1 pyramidal neurons. J Neurosci 2007; 27: 13909-13918.
12. Barco A, Alarcon JM, Kandel ER. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 2002; 108: 689-703.
13. Shimohata T, Nakajima T, Yamada M, Uchida C, Onodera O, Naruse S et al. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet 2000; 26: 29-36.
14. Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC. Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem 2004; 279: 4988-4999.
15. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 2002; 99: 13217-13221.
16. Park SA, Kim TS, Choi KS, Park HJ, Heo K, Lee BI. Chronic activation of CREB and p90RSK in human epileptic hippocampus. Exp Mol Med 2003; 35: 365-370.
17. Bach ME, Barad M, Son H, Zhuo M, Lu YF, Shih R et al. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci USA 1999; 96: 5280-5285.
18. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002; 35: 605-623.
19. Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci USA 2000; 97: 8093-8097.
20. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2: 589-598.
21. Ishimaru MJ, Ikonomidou C, Tenkova TI, Der TC, Dikranian K, Sesma MA et al. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 1999; 408: 461-476.
22. Shimohata M, Shimohata T, Igarashi S, Naruse S, Tsuji S. Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches-augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases. J Neurochem 2005; 93: 654-663.
23. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 2004; 114: 1624-1634.
24. Brooks-Kayal AR, Raol YH, Russek SJ. Alteration of epileptogenesis genes. Neurotherapeutics 2009; 6: 312-318.
25. Brightwell JJ, Gallagher M, Colombo PJ. Hippocampal CREB1 but not CREB2 is decreased in aged rats with spatial memory impairments. Neurobiol Learn Mem 2004; 81: 19-26.
26. Tomobe K, Okuma Y, Nomura Y. Impairment of CREB phosphorylation in the hippocampal CA1 region of the senescence-accelerated mouse (SAM) P8. Brain Res 2007; 1141: 214-217.
27. Porte Y, Buhot MC, Mons N. Alteration of CREB phosphorylation and spatial memory deficits in aged 129T2/Sv mice. Neurobiol Aging 2008; 29: 1533-1546.
28. Qiao X, Lu JY, Hofmann SL. Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response. BMC Neurosci 2007; 8: 95.
29. Haltia M. The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta 2006; 1762: 850-856.
30. Masedunskas A, King JA, Tan F, Cochran R, Stevens T, Sviridov D et al. Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration. FEBS Lett 2006; 580: 2637-2645.
31. Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009; 229: 12-26.
32. Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 2007; 44: 999-1010.
33. Barco A, Patterson S, Alarcon JM, Gromova P, Mata-Roig M, Morozov A et al. Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Neuron 2005; 48: 123-137.
34. Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ. Functional requirement for class I MHC in CNS development and plasticity. Science 2000; 290: 2155-2159.
35. Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ. The complement cascade: Yin-Yang in neuroinflammation-neuro-protection and-degeneration. J Neurochem 2008; 107: 1169-1187.
36. Gao Y, Deng K, Hou J, Bryson JB, Barco A, Nikulina E et al. Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron 2004; 44: 609-621.
37. Deng W, Neve RL, Rosenberg PA, Volpe JJ, Jensen FE. AMPA receptor subunit composition and CREB regulate oligodendrocyte excitotoxicity. J Biol Chem 2006; 281: 36004-36011.
38. Kitagawa K. CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J 2007; 274: 3210-3217.
39. Choi YS, Lee B, Cho HY, Reyes IB, Pu XA, Saido TC et al. CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's Disease. Neurobiol Dis 2009; 36: 256-268.
40. Viosca J, Malleret G, Bourtchouladze R, Benito E, Vronskava S, Kandel ER et al. Chronic enhancement of CREB activity in the hippocampus interferes with the retrieval of spatial information. Learn Mem 2009; 16: 198-209.